top of page
Medvin icon
Medvin Clinical Research

Call Toll Free:
 1 (855) MEDVIN-1

  • Instagram
  • Facebook
  • LinkedIn
lupus.png

Lupus Trials (SLE)

We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.

participating criteria.png

Participation Criteria

  • Must be at least 18 years of age.

  • Must have a diagnosis of SLE. within the last 2 years

  • Must have ongoing disease activity despite medication use.

  • Must not have any other major medical condition.

locations.png

Participating Locations

  • Apple Valley

  • Riverside

  • Menifee

  • Covina

  • Whittier

  • Tujunga

compensation.png

  • Earn up $1,900 participating ($100 per visit, 19 visits)

Compensation

medications.png

  • FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages

Medications

durations.png

  • 3 year study (19 visits)

Durations

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Systemic Lupus?
Do you have a history of any malignancy in the past 5 years?
Do you have a diagnosis of any other autoimmune diseases?
Have you previously been exposed to any biologics (Injections or Infusion medications)?

Trial Details

lupus.png

Lupus Trials (SLE)

We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.

lupus.png

Lupus Trials (SLE)

We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Systemic Lupus?
Do you have a history of any malignancy in the past 5 years?
Do you have a diagnosis of any other autoimmune diseases?
Have you previously been exposed to any biologics (Injections or Infusion medications)?
participating criteria.png

Participation  Criteria

  • Must be at least 18 years of age.

  • Must have a diagnosis of SLE. within the last 2 years

  • Must have ongoing disease activity despite medication use.

  • Must not have any other major medical condition.

locations.png

Participating Locations

  • Apple Valley

  • Riverside

  • Menifee

  • Covina

  • Whittier

  • Tujunga

compensation.png

  • Earn up $1,900 participating ($100 per visit, 19 visits)

Compensation

medications.png

  • FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages

Medications

durations.png

  • 3 year study (19 visits)

Durations

Trial Details

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Systemic Lupus?
Do you have a history of any malignancy in the past 5 years?
Do you have a diagnosis of any other autoimmune diseases?
Have you previously been exposed to any biologics (Injections or Infusion medications)?
participating criteria.png

Participation Criteria

  • Must be at least 18 years of age.

  • Must have a diagnosis of SLE. within the last 2 years

  • Must have ongoing disease activity despite medication use.

  • Must not have any other major medical condition.

locations.png

Participating Locations

  • Apple Valley

  • Riverside

  • Menifee

  • Covina

  • Whittier

  • Tujunga

compensation.png

  • Earn up $1,900 participating ($100 per visit, 19 visits)

Compensation

medications.png

Medications

  • FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages

durations.png

  • 3 year study (19 visits)

Durations

Trial Details

bottom of page